Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

BACKGROUND: The choice of chemotherapy in HER2-negative gastric cancer is based on centre’s preferences and adverse effects profile. No schedule is currently accepted as standard, nor are there any factors to predict response, other than HER2 status. We seek to evaluate whether Lauren type influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez Fonseca, Paula, Carmona-Bayonas, Alberto, Hernández, Raquel, Custodio, Ana, Cano, Juana Maria, Lacalle, Alejandra, Echavarria, Isabel, Macias, Ismael, Mangas, Monserrat, Visa, Laura, Buxo, Elvira, Álvarez Manceñido, Felipe, Viudez, Antonio, Pericay, Carles, Azkarate, Aitor, Ramchandani, Avinash, López, Carlos, Martinez de Castro, Eva, Fernández Montes, Ana, Longo, Federico, Sánchez Bayona, Rodrigo, Limón, Maria Luisa, Diaz-Serrano, Asun, Martin Carnicero, Alfonso, Arias, David, Cerdà, Paula, Rivera, Fernando, Vieitez, Jose Maria, Sánchez Cánovas, Manuel, Garrido, M, Gallego, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589993/
https://www.ncbi.nlm.nih.gov/pubmed/28765618
http://dx.doi.org/10.1038/bjc.2017.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589993/
https://www.ncbi.nlm.nih.gov/pubmed/28765618
http://dx.doi.org/10.1038/bjc.2017.245

Ejemplares similares